 |
 |
 |
 |
 |
 |
 |
 |
Goal: $50 million
Seventy percent of Rush’s research is funded by the National Institutes of Health — the gold standard for medical research. We have every reason to believe that we can double that contribution in the next decade — with philanthropic support to lay the groundwork.
Core research centers. Insights gleaned from research at the molecular level will make the next several years decisive ones for Rush in four interdisciplinary areas: neuroscience, heart, cancer and orthopedics. The campaign will make possible a broader, deeper and more comprehensive research commitment on all fronts. Support will provide the shared resources — equipment, labs, statisticians and scientists — that are essential to tackling disease.
Endowed research funds. By generating a steady stream of dependable income, endowed research funds enable Rush to plan for the long term, independent of the uncertainties of government funding. A strong research endowment also plays a critical role in attracting and retaining outstanding researchers.
Research seed funding. The early stages of research are often the hardest to fund. Seed funding enables
imaginative young researchers with exciting new ideas to establish track records
of success so that they may attract additional support and join the ranks of Rush’s
NIH-funded investigators.
